BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study. Clin Res Cardiol 2016;105:441-50. [DOI: 10.1007/s00392-015-0939-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review. Heliyon 2022;8:e09716. [PMID: 35770147 DOI: 10.1016/j.heliyon.2022.e09716] [Reference Citation Analysis]
2 Albert NM, Tyson RJ, Hill CL, DeVore AD, Spertus JA, Duffy C, Butler J, Patterson JH, Hernandez AF, Williams FB, Thomas L, Fonarow GC. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Am Heart J 2021;235:82-96. [PMID: 33497697 DOI: 10.1016/j.ahj.2021.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Raat W, Smeets M, Vandewal I, Broekx L, Peters S, Janssens S, Vaes B, Aertgeerts B. Cardiologists' perceptions on multidisciplinary collaboration in heart failure care - a qualitative study. BMC Health Serv Res 2021;21:170. [PMID: 33622318 DOI: 10.1186/s12913-021-06179-9] [Reference Citation Analysis]
4 Wei Q, Zhang L, Duan MF, Wang YM, Huang N, Song CR. Use of angiotensin II receptor blocker during pregnancy: A case report. Medicine (Baltimore) 2021;100:e24304. [PMID: 33546057 DOI: 10.1097/MD.0000000000024304] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Greene SJ, Tan X, Yeh YC, Bernauer M, Zaidi O, Yang M, Butler J. Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction. Heart Fail Rev 2021. [PMID: 33471236 DOI: 10.1007/s10741-021-10077-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 El Hadidi S, Vaughan C, Kerins D, Byrne S, Darweesh E, Bermingham M. Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service. Int J Clin Pharm 2021;43:1082-9. [PMID: 33411177 DOI: 10.1007/s11096-020-01220-z] [Reference Citation Analysis]
7 Rachamin Y, Meier R, Rosemann T, Flammer AJ, Chmiel C. Heart failure epidemiology and treatment in primary care: a retrospective cross-sectional study. ESC Heart Fail 2021;8:489-97. [PMID: 33159393 DOI: 10.1002/ehf2.13105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Smeets M, Vaes B, Aertgeerts B, Raat W, Penders J, Vercammen J, Droogne W, Mullens W, Janssens S. Impact of an extended audit on identifying heart failure patients in general practice: baseline results of the OSCAR-HF pilot study. ESC Heart Fail 2020. [PMID: 32969599 DOI: 10.1002/ehf2.12990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Packer M. Obesity-Associated Heart Failure as a Theoretical Target for Treatment With Mineralocorticoid Receptor Antagonists. JAMA Cardiol 2018;3:883-7. [PMID: 30046826 DOI: 10.1001/jamacardio.2018.2090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Smeets M, Aertgeerts B, Mullens W, Penders J, Vercammen J, Janssens S, Vaes B. Optimising standards of care of heart failure in general practice the OSCAR-HF pilot study protocol. Acta Cardiol 2019;74:371-9. [PMID: 30507291 DOI: 10.1080/00015385.2018.1507426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Durstenfeld MS, Katz SD, Park H, Blecker S. Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study. BMC Cardiovasc Disord 2019;19:194. [PMID: 31399059 DOI: 10.1186/s12872-019-1175-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Werner TR, Kunze AC, Stenzig J, Eschenhagen T, Hirt MN. Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue. Sci Rep 2019;9:11494. [PMID: 31391475 DOI: 10.1038/s41598-019-46818-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Niriayo YL, Kumela K, Gidey K, Angamo MT. Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors among Heart Failure Patients in Southwest Ethiopia. Biomed Res Int 2019;2019:9463872. [PMID: 31179336 DOI: 10.1155/2019/9463872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Smeets M, Vaes B, Mamouris P, Van Den Akker M, Van Pottelbergh G, Goderis G, Janssens S, Aertgeerts B, Henrard S. Burden of heart failure in Flemish general practices: a registry-based study in the Intego database. BMJ Open 2019;9:e022972. [PMID: 30617099 DOI: 10.1136/bmjopen-2018-022972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Wintrich J, Kindermann I, Böhm M. [Update on heart failure]. Herz 2020;45:158-69. [PMID: 29869700 DOI: 10.1007/s00059-018-4715-1] [Reference Citation Analysis]
16 El Hadidi S, Darweesh E, Byrne S, Bermingham M. A tool for assessment of heart failure prescribing quality: A systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 2018;27:685-94. [PMID: 29659109 DOI: 10.1002/pds.4430] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Smeets M, Henrard S, Aertgeerts B, Cools F, Janssens S, Vaes B. Methods to identify heart failure patients in general practice and their impact on patient characteristics: A systematic review. International Journal of Cardiology 2018;257:199-206. [DOI: 10.1016/j.ijcard.2017.06.108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hoeltzenbein M, Tissen-Diabaté T, Fietz AK, Zinke S, Kayser A, Meister R, Weber-Schoendorfer C, Schaefer C. Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study. Clin Res Cardiol 2018;107:679-87. [PMID: 29574489 DOI: 10.1007/s00392-018-1234-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Giezeman M, Arne M, Theander K. Adherence to guidelines in patients with chronic heart failure in primary health care. Scand J Prim Health Care 2017;35:336-43. [PMID: 29105550 DOI: 10.1080/02813432.2017.1397253] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
20 Legrand M, Ludes PO, Massy Z, Rossignol P, Parenica J, Park JJ, Ishihara S, AlHabib KF, Maggioni A, Miró Ò, Sato N, Cohen-Solal A, Fairman E, Lassus J, Harjola VP, Mueller C, Peacock FW, Choi DJ, Plaisance P, Spinar J, Kosiborod M, Mebazaa A, Gayat E; GREAT (Global Research on Acute Conditions Team) Network and INI-CRCT (Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists) network. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol 2018;107:214-21. [PMID: 29080909 DOI: 10.1007/s00392-017-1173-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
21 Helms TM, Müller A, Perings C, Köhler F, Leonhardt V, Rybak K, Sack S, Stockburger M. [The telemedical service centre as an essential element of the conceptual approach for telemonitoring of cardiac patients : Requirements on the service, quality, and technical realization of telemonitoring]. Herzschrittmacherther Elektrophysiol 2017;28:293-302. [PMID: 28840312 DOI: 10.1007/s00399-017-0527-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Vukadinović D, Lavall D, Vukadinović AN, Pitt B, Wagenpfeil S, Böhm M. True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis. Am Heart J 2017;188:99-108. [PMID: 28577687 DOI: 10.1016/j.ahj.2017.03.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
23 Morbach C, Wagner M, Güntner S, Malsch C, Oezkur M, Wood D, Kotseva K, Leyh R, Ertl G, Karmann W, Heuschmann PU, Störk S. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort. BMC Cardiovasc Disord 2017;17:108. [PMID: 28476146 DOI: 10.1186/s12872-017-0543-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Miró Ò, Müller C, Martín-sánchez FJ, Bueno H, Mebazaa A, Herrero P, Jacob J, Gil V, Escoda R, Llorens P; ICA-SEMES Research Group. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure. Clin Res Cardiol 2016;105:1021-9. [DOI: 10.1007/s00392-016-1014-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
25 Hoes AW. β blockers for heart failure. BMJ 2016;353:i2074. [PMID: 27099266 DOI: 10.1136/bmj.i2074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]